• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

VCC:GR

0.847 EUR 0.016 1.93%

As of 03:52:20 ET on 12/19/2014.

Snapshot for Vical Inc (VCC)

Open: 0.847 Day's Range: 0.847 - 0.860 Volume: 0
Previous Close: 0.831 52wk Range: 0.701 - 1.336 1-Yr Rtn: +12.63%

Stock Chart for VCC

No chart data available.
  • VCC:GR 0.860
  • 1D
  • 1M
  • 1Y
0.831
Interactive VCC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VCC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.1900
Est. PEG Ratio -
Market Cap (M EUR) 76.51
Shares Outstanding (M) 90.33
30 Day Average Volume 428
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VCC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VCC

Vical Incorporated develops gene-based pharmaceutical products for human therapy. The Company develops cancer product candidates, as well as develops vaccines for infectious diseases and gene-based delivery of therapeutic proteins for other disorders.

Vijay B SamantPresident/CEO/Acting CFOIgor P BilinskySenior VP:Corporate Dev
Anthony A RamosVP:Finance/Chief Acctg OfficerMammen P Mammen JrVP:Clinical Vaccines
More Company Profile & Key Executives for VCC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil